Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Dailong Li"'
Autor:
Dailong Li, Lu Xu, Jinxing Ji, Dan Bao, Juan Hu, Ying Qian, Yinjie Zhou, Zhuo Chen, Daojun Li, Xiaopeng Li, Xiaoling Zhang, Hao Wang, Changjun Yi, Menglu Shi, Yaqi Pang, Siqi Liu, Xinhua Xu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectiveTo evaluate the efficacy and safety of sintilimab combined with apatinib plus capecitabine in the treatment of unresectable hepatocellular carcinoma (HCC) to provide a more effective first-line treatment for patients with advanced HCC.Method
Externí odkaz:
https://doaj.org/article/e55bf02a83fb482b9bf4d7bec8b46ad3
Autor:
Dailong Li
Publikováno v:
BCP Business & Management. 38:2348-2356
With the increasingly close trade between China and the United States, a large number of soybeans grown in the United States were exported to the Chinese market, and the trade volume gradually increased. After decades of expansion, Sino-US agricultur
Publikováno v:
Medicine; 9/8/2023, Vol. 102 Issue 36, p1-10, 10p
Publikováno v:
Medicine; Sep2023, Vol. 102 Issue 35, p1-11, 11p
Publikováno v:
Medicine. 101(26)
Lymphovascular invasion is considered to be a high-risk pathological feature after radical resection of gastric cancer, but the relationship between lymphovascular invasion and the prognosis of stage I gastric cancer is still controversial. Therefore
Autor:
Lu, Xu, Dailong, Li, Jinxing, Ji, Zhuo, Chen, Xi, Tang, Dian, Chen, Xin, Li, Dan, Bao, Fan, Yan, Yaqi, Pang, Siqi, Liu, Yunfeng, Zhou, Xinhua, Xu
Publikováno v:
Am J Cancer Res
Nasopharyngeal carcinoma (NPC) is not only a common malignant disease of the head and neck, but also presented as locoregionally advanced NPC at diagnosis with poor prognosis. The efficacy of current chemoradiotherapy is unsatisfactory; therefore, in
Publikováno v:
Cancer Management and Research. 12:7263-7275
Detection of circulating tumor cells (CTC) is an important liquid biopsy technique that has advanced considerably in recent years. To further advance the development of technology for curing cancer, several CTC technologies have been proposed by vari
Publikováno v:
Medicine. 101:e32164
Icotinib is the first generation of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) independently developed in China, which has been widely used in the treatment of advanced EGFR mutation-positive nonsmall cell lung cancer (NSCL
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(4)
Sorafenib combined with transcatheter arterial chemoembolization (TACE) is one of the common methods in the clinical treatment of advanced hepatocellular carcinoma (HCC), but its efficacy and safety are still controversial. Therefore, we used meta-an
Publikováno v:
Medicine. 101:e30815
The relationship between the expression of nm23-H1 and the invasion and prognosis of non-small cell lung cancer (NSCLC) is still controversial. Therefore, we conducted a meta-analysis to determine the prognostic value of nm23-H1 in patients with NSCL